HIV and Smoking, A Deadly Intersection

Cigarettes More Harmful to People With HIV Than HIV Itself

Justin Sullivan/Getty Images

Cigarette smoking remains among the most daunting and detrimental health concerns facing people with HIV today. Compared to the general U.S. population, where the smoking prevalence has dropped in recent years to around 21%, as many as 42% of people living with HIV are classified as current smokers. That's an alarming statistic, and one that is directly linked to an increase in both HIV-related co-mordibities and premature death.

Why Are HIV-Positive People Twice as Likely to Smoke?

There is little research available to fully explain the disproportionately high rates of smoking within the HIV population. Some studies have suggested that high levels of anxiety and depression play an important part, and that many turn to nicotine as a means to cope with the daily stresses of HIV.

But it's unclear whether these emotional issues are an instigating factor for tobacco use, or if they simply makes cessation efforts less effective for those living with HIV.

Data is conflicting. According to a statistical analysis from the U.S. Centers for Disease Control and Infection (CDC), current HIV-positive smokers in U.S. tend to be older rather than younger, with 58% aged 45 and older, 40% aged 25-44, and only 2% aged 18-24.

These numbers suggest that HIV-related stress is not necessarily a causal factor for tobacco use, insofar as younger HIV-positive smokers—who comprise 26% of new infections—are far less likely to smoke than even their HIV-negative counterparts (2% versus 19%).

Rather, the figures echo a general trend in the U.S., whereby older smokers are simply less likely to explore smoking cessation than younger smokers (84% versus 66%).

By contrast, sexual orientation plays little part in smoking rates. In fact, the numbers are somewhat counterintuitive, with just as many heterosexuals smoking (51%) as gay, lesbians, or bisexuals (49%)—despite the fact that new infections among men who have sex with men (MSM) are three time higher than among heterosexuals.

This means that a greater percentage of HIV-positive smokers are, in fact, heterosexual. Why this is remains unclear—particularly since smoking rates among gays, lesbians, and bisexuals in the general population are nearly twice that of heterosexuals, according to a 2010 report from the American Lung Association.

How Smoking Directly Impacts People With HIV

Smoking has a far greater impact on the prognosis of HIV-infected people in the developed world than any HIV-related illness. This is according to a 2013 study from Copenhagen University Hospital, which showed that smoking, in and of itself, reduces life expectancy in people with HIV by 12.3 years.

Furthermore, the risk of mortality (whether HIV-related and non-HIV related) was seen to be as much as five times greater in HIV-positive smokers than HIV-positive people who have never smoked.

Among the HIV-specific smoking risks:

  • Smoking is the single greatest risk factor associated with acute heart disease (ACS) in people with HIV. According to research from the University of Barcelona, the contribution of smoking to ACS in HIV-positive adults was greater than the contributions of either diabetes or hypertension, and was almost twice as high as that in HIV-negative adults (54% versus 31%). The use of antiretrovirals or a person's CD4 count/viral load appeared to have little-to-no impact on whether HIV-positive smokers developed ACS or not.
  • Smoking is considered the foremost risk factor in the development of lung cancer. In fact, there is a 14-fold increase in lung cancer risk among HIV-positive smokers, independent of the person's CD4 count or history of HIV-related lung disease (e.g. tuberculosis, PCP). Research from the Swiss HIV Cohort Study suggests that survival rates are poor for HIV-positive smokers who develop lung malignancies, with only 14% still alive two years after diagnosis. That said, former smokers were shown to have significantly lower risk than current smokers, highlighting the importance of smoking cessation in those with HIV.
  • Smoking further raises the risk of chronic obstructive pulmonary disease (COPD) and community-acquired bacterial pneumonia. Current smokers with HIV not only have more respiratory symptoms than non-smoking counterparts, they have a two-fold increase in the risk of death. Other studies have shown the relationship between smoking and oral/esophageal candidiasis (the latter of which is classified an AIDS-defining condition).
  • There is a strong association between smoking and human papillomavirus (HPV) infection in both women and men with HIV. HIV-positive women who smoke have between two and three times the risk for HPV infection than HIV-positive women who don't smoke. Similarly, smoking in HIV-positive men was associated with an increased risk for the development of precancerous HPV lesions. Recurrent HPV infections are directly linked to an increased risk of cervical cancer in women and anal cancer in men. Numerous studies suggest that smoking has adverse effects on a person's immunity, both systemic and mucosal (the latter of which include the protective Langerhans cells that line the cervix and anus). CD4 counts under 350 cells/mL are also considered an associative contributor.
  • Cigarette smoking can increase woman's risk of transmitting HIV to her baby during delivery, with premature membrane ruptures occurring more frequently in mothers who had smoked during the first trimester of their pregnancy. All told, the risk of vertical transmission was shown to be as high as three times that of non-smoking women with HIV.
  • Smoking is also associated with an increased risk of bone density loss (e.g. osteopenia, osteoporosis), and is considered an independent risk factor for fractures among those with HIV. Older age and white race are also predictors of incident fractures.

Benefits of Quitting

The long- and short term benefits of quitting are both undeniable and clear. Smoking cessation progressively reduces the risk of cardiovascular disease in people with HIV, with one study demonstrating a reduction in risk of nearly 65% after three years. (Research from the Aquitaine Cohort Study in France suggests that cessation may, in fact, be the only factor associated with improvement of cardiovascular risk in people with HIV—greater even than lipid-lowering drugs or antiretroviral therapy.)

Similarly, the risk of lung cancer can be reduced by as much as 50% in HIV-positive smokers who have quit for a year or more. Comparable results are seen with patients with COPD, bacterial pneumonia, and other infectious and non-infectious respiratory conditions.

It's equally important to stress that sooner is better than later when it comes to quitting, particularly for those with compromised immune systems. Research from the Anderson Cancer Center at the University of Texas showed that smoking cessation can reduce the burden of HIV-related symptoms in patients within as little as three months, and that symptoms can continue to decrease as period of time without smoking increases.

Moreover, smoking abstinence is independently associated with improved adherence for those on antiretroviral therapy.

Learn more about smoking cessation programs for people with HIV.


U.S. Centers for Disease Control and Prevention (CDC). "Cigarette smoking among adults - United States, 2011." Morbidity and Mortality Weekly Report (MMWR). November 9, 2012; 61(44):889-994.

Mdodo, R.; Frazier, E.; Mattson, C.; et al. "Cigarette smoking among HIV+ adults in care: Medical Monitoring Project, US, 2009." 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013). Atlanta, Georgia; March 3-6, 2013: Abstract 775.

Messer, K.; Trinidad, D.; Al-Delaimy, W.; et al. "Smoking cessation rates in the United States: a comparison of young adult and older smokers." American Journal of Public Health. February 2008; 98(2):317-322.

American Lung Association. "Smoking Out a Deadly Threat: Tobacco Use in the LGBT Community." Disparities in Lung Health Series. Washington, D.C.; published June 29, 2010.

Helleberg M.; Afzal, S.; Kronborg, G.; et al. "Mortality attributable to smoking among HIV-1-infected individuals: a nationwide population-based cohort study." Clinical Infectious Diseases. March 2013; 56(5): 723-734.

Sanchez-Calvo, M.; Perelló, R.; Pérez, I.; et al. "Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies." HIV Medicine. October 22, 2012; 14(1):40-48.

Clifford G.; Lise, M.; Franceschi, S.; et al. "Lung cancer in the Swiss HIV cohort study: role of smoking, immunodeficiency and pulmonary infection." British Journal of Cancer. January 12, 2012; 106(3): 447-452.

Crothers, K.; Griffith, T.; McGinnis, K.; et al. "The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans." Journal of General Internal Medicine. December 2005; 20(12):1142-1145.

Soysa, N. and Ellepola. A. "The impact of cigarette/tobacco smoking on oral candidosis: an overview." Oral Diseases. 2005, 11:268-273.

Minkoff, H.; Feldman, G.; Strickler, H.; et al. "Relationship between Smoking and Human Papillomavirus Infections in HIV-Infected and -Uninfected Women." Journal of Infectious Diseases. 2004; 189(10): 1821-1828.

Schwartz L.; Castle, P.; Follansbee, S.; et al. "Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men." Journal of Infectious Diseases. August 1, 2013; online edition.

Burns, D.; Landesman, S.; Muenz, L.; et al. "Cigarette Smoking, Premature Rupture of Membranes, and Vertical Transmission of HIV-1 Among Women With Low CD4+ Levels." Journal of Acquired Immune Deficiency Syndrome. July 1994; 7(7); online publication.

Hansen, A.; Gerstoft, J;. Kronborg, G.; et al. "Incidence of low and high-energy fractures in persons with and without HIV infection; a Danish population-based cohort study." AIDS. 2012; 26:285-293.

Borderi, M.; Gibellini, D.; Vescini, F.; et al. "Metabolic bone disease in HIV Infection." AIDS. 2009: 23(11):1297-1310.

Petoumenos, K.; Worm, S.; Reiss, P.; et al. "Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)." HIV Medicine. August 2011; 12(7):214-421.

Thiébaut, R.; Aurillac-Lavignolle, V.; Bonnet, F.; et al. "Change in atherosclerosis progression in HIV infected patients: ANRS Aquitaine Cohort, 1999-2005." AIDS. 2005; 19 (7): 729-731.

Sigel, K.; Wisnivesky, J.; Justice, A.; et al. "HIV Infection Is an Independent Risk Factor for Lung Cancer." 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010). San Francisco; February 16-19, 2010: Abstract 30.

Vidrine, D.; Arduino, R.; and Gritz, E. "The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS." AIDS Patient Care and STDs. 2007; 21(9):659-666.

Lifson, A.; Neuhaus, J.; Arribas, J.; et al. "Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial." American Journal of Public Health. 2010; 100(10);1896-1903.

Continue Reading